{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:57:18Z","timestamp":1793750238262,"version":"4.6.1"},"reference-count":20,"publisher":"Centers for Disease Control MMWR Office","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7139e1","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T09:49:40Z","timestamp":1663667380000},"page":"1241-1246","source":"Crossref","is-referenced-by-count":16,"title":["<i>Vital Signs:<\/i>\n                    Use of Recommended Health Care Measures to Prevent Selected Complications of Sickle Cell Anemia in Children and Adolescents \u2014 Selected U.S. States, 2019"],"prefix":"10.15585","volume":"71","author":[{"given":"Laura A.","family":"Schieve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen M.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda B.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karon","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis L.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Hulihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shammara","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rhie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi","family":"Dupervil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Craig","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R1","doi-asserted-by":"publisher","first-page":"e1915374","DOI":"10.1001\/jamanetworkopen.2019.15374","article-title":"Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease.","volume":"2","author":"Lubeck","year":"2019","journal-title":"JAMA Netw Open"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R2","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R3","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1056\/NEJMp2022125","article-title":"When actions speak louder than words\u2014racism and sickle cell disease.","volume":"383","author":"Power-Hays","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R4","first-page":"4","article-title":"Differences in the clinical and genotypic presentation of sickle cell disease around the world.","volume":"15","author":"Saraf","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R6","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors.","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R7","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1182\/blood-2009-05-220921","article-title":"Sickle cell disease and stroke.","volume":"114","author":"Verduzco","year":"2009","journal-title":"Blood"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1177\/1535370216642048","article-title":"Minireview: prognostic factors and the response to hydroxyurea treatment in sickle cell disease.","volume":"241","author":"Wang","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R9","doi-asserted-by":"publisher","first-page":"e1062","DOI":"10.1097\/MPH.0000000000002103","article-title":"Transcranial Doppler screening in a current cohort of children with sickle cell anemia: results from the DISPLACE study.","volume":"43","author":"Kanter","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/jamapediatrics.2015.4859","article-title":"Transcranial Doppler screening among children and adolescents with sickle cell anemia.","volume":"170","author":"Reeves","year":"2016","journal-title":"JAMA Pediatr"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R11","doi-asserted-by":"publisher","first-page":"e20183285","DOI":"10.1542\/peds.2018-3285","article-title":"Hydroxyurea use for sickle cell disease among Medicaid-enrolled children.","volume":"144","author":"Brousseau","year":"2019","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1177\/0009922814553429","article-title":"Physician attitude, awareness, and knowledge regarding guidelines for transcranial Doppler screening in sickle cell disease.","volume":"54","author":"Reeves","year":"2015","journal-title":"Clin Pediatr (Phila)"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R13","doi-asserted-by":"publisher","first-page":"2333794X19847026","DOI":"10.1177\/2333794x19847026","article-title":"Barriers to pediatric sickle cell disease guideline recommendations","volume":"6","author":"Cabana","year":"2019","journal-title":"Glob Pediatr Health"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R14","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1182\/bloodadvances.2020001701","article-title":"Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.","volume":"4","author":"Hodges","year":"2020","journal-title":"Blood Adv"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R15","doi-asserted-by":"publisher","first-page":"e050880","DOI":"10.1136\/bmjopen-2021-050880","article-title":"Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.","volume":"11","author":"Smeltzer","year":"2021","journal-title":"BMJ Open"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/1475-6773.13257","article-title":"Performance of ICD-10-CM diagnosis codes for identifying children with sickle cell anemia.","volume":"55","author":"Reeves","year":"2020","journal-title":"Health Serv Res"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R17","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/pbc.25432","article-title":"The accuracy of using ICD-9-CM codes to determine genotype and fever status of patients with sickle cell disease.","volume":"62","author":"Eisenbrown","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R18","doi-asserted-by":"publisher","first-page":"e28831","DOI":"10.1002\/pbc.28831","article-title":"Recommendation to reality: closing the transcranial Doppler screening gap for children with sickle cell anemia.","volume":"68","author":"Singh","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R19","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1097\/pq9.0000000000000379","article-title":"Improving preventive care for children with sickle cell anemia: a quality improvement initiative.","volume":"6","author":"Cabana","year":"2020","journal-title":"Pediatr Qual Saf"},{"key":"key-10.15585\/mmwr.mm7139e1-202209291041-R20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bjh.17323","article-title":"Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia.","volume":"194","author":"Ware","year":"2021","journal-title":"Br J Haematol"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T10:59:05Z","timestamp":1664449145000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7139e1.htm?s_cid=mm7139e1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":20,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2022,9,30]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7139e1","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,30]]},"published":{"date-parts":[[2022,9,30]]}}}